Yeah, interesting to see if we will get a similar valuation that Murray Meds got in that deal.
It doesnt look bad for potential buyers, I would love to have a go at running it.
Its not the best time to sell, so I bet could pick this up for bargain prices, given the current market and state of cannabis ETFs. Lets see what we get for it. $5+ mill would be a nice addition to the cash balance and would put off any need for a CR, good sale and then approval of debt facility from a bank, woud bode well for ECS.
Ann: Focussed Strategy to Maximise Growth, page-45
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ECS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.32M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.4¢ | $21.35K | 1.447M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 6522135 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 252000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| ECS (ASX) Chart |